$10.66
-0.20-1.84%
At close: Nov 13, 4:00 PM EST
$10.43
-0.23-2.16%
After Hours: Nov 13, 4:26 PM EST
Bioventus Inc
BVSNASDAQ
Bioventus rose 45.0% from $7.35 to $10.66, ahead of the S&P 500's +12.3%. Its worst day was Nov 3 (−16.8%), and its low came Nov 20 at $6.53.
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Bioventus closed at its lowest level of the year, 11.2% below where the year started.
−2.8% · S&P 500 −1.5%
EPS of $0.24 beat the $0.22 estimate on $157.9M revenue (est. $154.0M); FY revenue guidance of $600.0M–$610.0M against the $600.7M consensus.
Story events cover the past 12 months · Times ET
+7.4% · S&P 500 −0.6%
EPS of $0.15 beat the $0.07 estimate on $132.1M revenue (est. $129.8M); FY revenue guidance of $600.0M–$610.0M against the $604.7M consensus.
+2.2% · S&P 500 +1.4%
Bioventus shares fell 13.2%, while the S&P 500 rose 0.2%.
−13.2% · S&P 500 +0.2%
Bioventus shares rose 12.4%, while the S&P 500 rose 0.9%.
+12.4% · S&P 500 +0.9%
EPS of $0.22 beat the $0.21 estimate on $153.2M revenue (est. $155.3M); FY revenue guidance of $600.0M–$610.0M against the $605.1M consensus.
+13.7%, the year's best day, on 3M shares, the year's heaviest volume · S&P 500 −0.2%
EPS of $0.17 beat the $0.16 estimate on $142.4M revenue (est. $149.5M); FY revenue guidance of $590.0M–$595.0M against the $604.6M consensus.
−16.8%, the year's worst day · S&P 500 +0.3%
Where it ended: a close of $10.66 on Nov 13, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $0.24, revenue est. $165.4M).
Nothing in the past 12 months.
All BVS dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BVS and SPY from Benzinga historical bars. Not investment advice.
